A risk score based on procalcitonin for predicting acute kidney injury in COVID-19 patients

A risk score based on procalcitonin for predicting acute kidney injury in COVID-19 patients

Background: Acute kidney injury (AKI) has been reported developing commonly in coronavirus disease 2019 (COVID-19) patients and could increase the risk of poor outcomes in these patients. We design this study to explore the value of serum procalcitonin (PCT) on predicting AKI and construct risk scor...

Full description

Bibliographic Details
Main Authors: He, M. (Author), Kang, Y. (Author), Wang, R.R (Author)
Format: Article
Language:English
Published: John Wiley and Sons Inc 2021
Subjects:
acute kidney failure
acute kidney injury
Acute Kidney Injury
adult
Adult
aged
Aged
Aged, 80 and over
arterial oxygen saturation
Article
biological marker
biomarker
Biomarkers
blood
China
complication
controlled study
coronavirus disease 2019
COVID-19
disease risk assessment
disease severity
female
Female
hospital admission
human
Humans
incidence
major clinical study
male
Male
middle aged
Middle Aged
multivariate logistic regression analysis
nasopharyngeal swab
odds ratio
prediction
predictive value
procalcitonin
Procalcitonin
protein blood level
receiver operating characteristic
risk assessment
Risk Assessment
risk factor
Risk Factors
SARS-CoV-2
urea
urea nitrogen blood level
very elderly
virology
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items